[1]葛高顺,林 玲,倪二茹,等.厦门地区三例Brugada 综合征患者SCN5A 基因突变分析[J].现代检验医学杂志,2023,38(02):81-85+101.[doi:10.3969/j.issn.1671-7414.2023.02.015 ]
　GE Gao-shun,LIN Ling,NI Er-ru,et al.Analysis of SCN5A Gene Mutation in Three Patients with Brugada Syndrome in Xiamen[J].Journal of Modern Laboratory Medicine,2023,38(02):81-85+101.[doi:10.3969/j.issn.1671-7414.2023.02.015 ]
点击复制

厦门地区三例Brugada 综合征患者SCN5A 基因突变分析()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第38卷
期数:
2023年02期
页码:
81-85+101
栏目:
论著
出版日期:
2023-03-15

文章信息/Info

Title:
Analysis of SCN5A Gene Mutation in Three Patients with Brugada Syndrome in Xiamen
文章编号:
1671-7414（2023）02-081-06
作者:
葛高顺1; 林 玲2; 倪二茹1; 谢华斌1
（1.厦门大学附属心血管病医院检验科 /厦门市心血管疾病精准医学重点实验室，福建厦门 361009；2. 厦门市中医院检验科，福建厦门 361010)
Author(s):
GE Gao-shun1;  LIN Ling2;  NI Er-ru1;  XIE Hua-bin1
（1.Department of Laboratory Medicine, Cardiovascular Hospitals of Xiamen University/Xiamen Key Laboratory of Precision Medicine for Cardiovascular Disease, Fujian Xiamen 361009, China; 2.Department of Laboratory Medicine, Xiamen Hospital of Tradional Chin
关键词:
Brugada综合征; SCN5A; 厦门
分类号:
R541.78；Q754
DOI:
10.3969/j.issn.1671-7414.2023.02.015
文献标志码:
A
摘要:
目的 探讨厦门地区３例 Brugada综合征患者 SCN5A基因突变情况。方法 选取 2011年 1月～2022年 6月到厦门大学附属心血管病医院就诊的 3例 Brugada综合征患者作为观察组，同期 20例健康体检者作为对照组，收集两组人群的常规生化与心肌标志物检测结果。采集观察组全血后提取基因组 DNA，应用高通量测序平台对 Brugada综合征相关基因的目标区域测序，再预测蛋白质三维结构，比较国内已报道的 Brugada综合征相关新发疑似致病 SCN5A基因突变。结果 观察组与对照组的常规生化与心肌标志物检测结果均无明显差异，目标区域捕获测序结果显示有 2位受检者都携带 SCN5A c · 219delA移码突变，该突变导致 74位的谷氨酸变成了丝氨酸，并产生新的阅读框架，终止于第 74号密码子下游 23位密码子处，产生一个缩短并变异的 RNA以及蛋白。另一位受检者携带 SCN5A c·584G>A无义突变，该突变会导致编码蛋白序列提前终止，产生一个截短的蛋白，可能会对蛋白质的结构和功能产生较大影响。这两个点突变都未有文献报道，在各大公共数据库中均没有被检索到，根据美国医学遗传学与基因组学协会（ACMG）评估指南，定义该位点为疑似致病突变的变异。结论 SCN5A c · 219delA和 SCN5A c · 584G>A点突变是 Brugada综合征的致病原因。
Abstract:
Objective To explore the SCN5A gene mutations in 3 patients with Brugada syndrome in Xiamen. Methods From January 2011 to June 2022, 3 patients with Brugada syndrome who went to the Cardiovascular Hospital of Xiamen University were selected as the observation group, and 20 patients with healthy physical examination during the same period were selected as the control group, and the routine biochemical and myocardial marker detection results of the two group were collected. The whole blood of the observation group was collected to extracte the genomic DNA, and the target regions of Brugada syndrome-related genes was sequenced using the high-throughput sequencing platform, then the three-dimensional structure of the protein was predicted, and the mutations of the newly suspected pathogenic SCN5A gene related to Brugada syndrome-reported in China were compared. Results There were no significant differences in the results of biochemical and myocardial markers between the two groups. Target region capture sequencing showed that two observation patients carried SCN5A c ·219delA frameshift mutation, changed the glutamate at position 74 to serine and produced a new reading frame, which terminated at codon 74 downstream codon 23, resulting in a shortened and mutated RNA and protein. The other observation patient carried SCN5A c ·584G>A anonsense mutation, which caused premature termination of the coding protein sequence, produced a truncated protein, which could had a significant impact on the structure and function of the protein. These two mutations had not been reported in the previous literature and databases. According to the American College of Medical Genetics and Genomics (ACMG) assessment guidelines, these two mutations were defined as suspected pathogenic mutations. Conclusion SCN5A c · 219delA and SCN5A c · 584G>A were found in this study may be the causative cause of Brugada syndrome.

参考文献/References:

[1] MARSMAN E M J, POSTEMA P G, REMME C A. Brugada syndrome: update and future perspectives [J]. Heart, 2022, 108(9): 668-675.
[2] CERRONE M, COSTA S, DELMAR M. The genetics of brugada syndrome [J]. Annu Rev Genomics Hum Genet, 2022, 23: 255-274.
[3] 任法鑫 , 杨钧国 , 李伟 , 等 .Brugada综合征相关基因 SCN5A新突变位点的检测 [J].中华心律失常学杂志 ,2003,7(6):16-19. REN Faxin, YANG Junguo, LI Wei, et al.The novel SCN5A mutation of Brugada syndrome in a Chinese male patient[J]. Chinese Journal of Cardiac Arrhythmias,2003,7(6):16-19.
[4] 梁鹏 , 刘文玲 , 胡大一 , 等．Brugada综合征 SCN5A基因的三个新突变 [J]．中华心血管病杂志 , 2006, 34(7): 616-619. LIANG Peng, LIU Wenling, HU Dayi, et al. Novel SCN5A gene mutations associated with Brugada syndrome: V95I, A1649V and delF1617[J]. Chinese Journal of Cardiology, 2006, 34(7): 616-619.
[5] 田莉 , 祝建芳 , 杨钧国 , 等．中国一家系 Brugada综合征相关基因 SCN5A突变位点的检测 [J]．中华心血管病杂志 , 2007, 35(12): 1122-1125． TIAN Li, ZHU Jianfang, YANG Junguo, et al. Gene (SCN5A) mutation analysis of a Chinese family with Brugada syndrome[J]. Chinese Journal of Cardiology, 2007, 35(12): 1122-1125.
[6] 阮发晖 , 孟素荣 , 陈哲明 , 等．Brugada综合征患者 SCN5A基因突变检测 [J]．心脏杂志 , 2007, 19(2): 218-221． RUAN Fahui, MENG Surong, CHEN Zheming, et al. Detection of a novel SCN5A gene mutation(G1712C）in patients with asymptomatic Burgada syndrome [J]. Chinese Heart Journal, 2007, 19(2): 218-221.
[7] 刘福强 , 李岩 , 谢勇 , 等．Brugada综合征患者 SCN5A基因突变检测 [J]．实用医学杂志 , 2012, 28(14): 2354-2355． LIU Fuqiang, LI Yan, XIE Yong, et al. Detection of a novel SCN5A gene mutation(G1712C)in patients with asymptomatic Burgada syndrome[J]. The Journal of Practical Medicine, 2012, 28(14): 2354-2355.
[8] BRUGADA P, BRUGADA J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report[J]. Journal of the American College of Cardiology, 1992, 20(6): 1391-1396.
[9] PRIORI S G, WILDE A A, HORIE M, et al. HRS/ EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013[J]. Heart Rhythm, 2013, 10(12): 1932-1963.
[10] ANTZELEVITCH C, YAN Ganxin, ACKERMAN M J, et al. J-Wave syndromes expert consensus conference report: emerging concepts and gaps in knowledge[J]. Europace, 2017, 19(4): 665-694.
[11] KAWADA S, MORITA H, ANTZELEVITCH C, et al. Shanghai score system for diagnosis of brugada syndrome: validation of the score system and system and reclassification of the patients[J]. JACC Clinical Electrophysiology, 2018, 4(6): 724-730.
[12] MARTíNEZ-BARRIOS E, ARBELO E, CESAR S, et al. Brugada syndrome in women: what do we know after 30 years?[J]. Frontiers in Cardiovascular Medicine, 2022, 9: 874992.
[13] CICONTE G, MONASKY M M, SANTINELLI V, et al. Brugada syndrome genetics is associated with phenotype severity[J]. European Heart Journal, 2021, 42(11): 1082-1090.
[14] ASATRYAN B, MEDEIROS-DOMINGO A. Emerging implications of genetic testing in inherited primary arrhythmia syndromes[J]. Cardiology in Review, 2019,27(1): 23-33.
[15] CAMPUZANO O, SARQUELLA-BRUGADA G, CESAR S, et al. Update on genetic basis of brugada syndrome: monogenic, polygenic or oligogenic?[J]. International Journal of Molecular Sciences, 2020, 21(19): 7155.
[16] KAPPLINGER J D, TESTER D J, ALDERS M, et al. An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing[J]. Heart Rhythm, 2010, 7(1): 33-46.
[17] HOSSEINI S M, KIM R, UDUPA S, et al. Reappraisal of reported genes for sudden arrhythmic death: Evidence-Based evaluation of gene validity for brugada syndrome[J]. Circulation, 2018, 138(12): 1195-1205.

备注/Memo

备注/Memo:
收稿日期：2022-09-17修回日期：2022-12-12
作者简介：葛高顺（1986-），男，硕士研究生，主管技师，研究方向：分子生物学， E-mail:gegaoshun87@163.com。
通讯作者：谢华斌（1970-），男，本科，主任技师，研究方向：临床检验诊断学， E-mail:xmsccl@126.com。

更新日期/Last Update: 2023-03-15